Work

Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy

Year: 2019
Type: review
Abstract: : Contrast agents (CAs) play a crucial role in high-quality magnetic resonance imaging (MRI) applications. At present, as a result of the Gd-based CAs which are associated with renal fibrosis as well as the inherent dark imaging characteristics of superparamagnetic iron oxide nanoparticles, Mn-based CAs which have a good biocompatibility and bright images are considered ideal for MRI. In addition, manganese oxide nanoparticles (MONs, such as MnO, MnO 2 , Mn 3 O 4 , and MnO x ) have attracted attention as T1-weighted magnetic resonance CAs due to the short circulation time of Mn(II) ion chelate and the size-controlled circulation time of colloidal nanoparticles. In this review, recent advances in the use of MONs as MRI contrast agents for tumor detection and diagnosis are reported, as are the advances in in vivo toxicity, distribution and tumor microenvironment-responsive enhanced tumor chemotherapy and radiotherapy as well as photothermal and photodynamic therapies. Keywords: manganese oxide nanoparticles, MRI, multimodal imaging, contrast agent, tumor therapy
Institution: Xidian University
Language: English
Open Access status: gold
Estimated APC paid: $2,836
OpenAlex ID: W2981241448
FWCI: 1.736
Cites: 138
Cited by: 262
Related to: 9